Sun Pharmaceutical Industries Ltd Board approves interim dividend of Rs. 5.50
Posted On: 2021-01-29 07:19:27 (Time Zone: Arizona, USA)
The Board of Directors of Sun Pharmaceutical Industries Ltd at its meeting held today i.e. January 29, 2021 has declared interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. l/- each of the Company for the financial year ending on March 31, 2021.
The Board of Directors of the Company has fixed Wednesday, February 10, 2021 as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive payment towards Interim Dividend of the Company for the financial year 2020-21 declared today. The payment of the interim dividend would be made to the eligible shareholders on or before February 19, 2021.
The Reserve Bank of India has through an order dated January 08, 2021 cancelled the licence of Vasantdada Nagari Sahakari Bank Ltd., Osmanabad, Maharashtra to carry on banking business, with effect from the close of business on January 11, 2021.
The Commissioner for Cooperation and Registrar of Cooperative Societies (RCS), Maharashtra has also been requested to issue an order for winding up the bank and appoint a liquidator for the bank. The Reserve Bank cancelled the licence of the bank as the bank has failed to comply with the requirements of Section 11(1) read with Section 56 of BR Act.
“The bank has become disentitled to carry on the business of banking in India, by reason of the cancellation of its licence issued to it by the Reserve Bank of India, under Section 22(1) read with Section 56 of BR Act as it has failed to comply with the requirements of Section 22(3) (a), 22(3) (b), 22(3) (c), 22(3) (d) and 22(3) (e) of BR Act”, reads a release from the RBI.